The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Plasma Glucose Levels Throughout the Day and HbA1c Interrelationships in Type 2 Diabetes
Abstract
OBJECTIVE—To evaluate the extent of plasma glucose excursions with meals, the relations between plasma glucose levels at different times of the day, and the relations between the latter and HbA1c in non–insulin-treated type 2 diabetic subjects. RESEARCH DESIGN AND METHODS—Daily glucose profiles were assessed in non–insulin-treated type 2 diabetic patients. Outpatients at the diabetes clinic (n = 371; one daily plasma glucose profile) and at home (n = 30; five daily blood glucose profiles over 1 month) as well as inpatients (n = 455; profile of plasma glucose on the day of admission) were examined. Subjects had plasma/blood glucose assessment before and 2–3 h after breakfast, lunch, and dinner. HbA1c was also measured. RESULTS—After the meals many subjects had glucose levels >8.9 mmol/l (160 mg/dl) and/or glucose excursions >2.2 mmol/l (40 mg/dl). This was also often found when HbA1c was satisfactory (<7%). The coefficients of simple correlation among plasma/blood glucose at different times of the day ranged from 0.52 to 0.88. Correlations between HbA1c and plasma/blood glucose at different times of the day ranged from 0.44 to 0.67. The strongest correlation was between HbA1c and mean daily glucose (r = 0.57–0.69). Multiple regression analyses showed that premeal but not postmeal plasma/blood glucose levels were independent predictors of HbA1c. CONCLUSIONS—These results suggest that 1) the majority of non–insulin-treated type 2 diabetic patients have exaggerated plasma/blood glucose excursions with meals, and many of them have higher-than-recommended glucose concentrations 2 h after the meals; 2) plasma/blood glucose levels throughout the day are not as strongly interrelated as one might believe; and 3) HbA1c is more related to preprandial than postprandial plasma/blood glucose levels. These findings have potential implications for treatment and monitoring of metabolic control in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“only in two small series of subjects with type 2 diabetes have data on circadian glucose levels been collected, and the results were partially conflicting [13][14][15][16].”
From Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus (2006) · cites this paper as [13]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Glucose Tolerance and Cardiovascular Mortality: Comparison of Fasting and 2-Hour Diagnostic Criteria
(2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.3.397 · Cited by 1,371
Malmberg, K. (1997) · BMJ · doi:10.1136/bmj.314.7093.1512 · Cited by 1,286
Hanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
Williams, S. B., Goldfine, A. B., Timimi, F. K., Ting, H. H., Roddy, M.-A., Simonson, D. C., & Creager, M. A. (1998) · Circulation · doi:10.1161/01.cir.97.17.1695 · Cited by 793
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
Shichiri, M., Kishikawa, H., Ohkubo, Y., & Wake, N. (2000) · PubMed · Cited by 727
A desktop guide to Type 2 diabetes mellitus
European Diabetes Policy Group, 1. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00166.x · Cited by 670
de Vegt, F., Dekker, J. M., Ruhé, H. G., Stehouwer, C. D. A., Nijpels, G., Bouter, L. M., & Heine, R. J. (1999) · Diabetologia · doi:10.1007/s001250051249 · Cited by 611
Association, A. D. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.775 · Cited by 464
Cited by
Sorted by citations
Items 101–200 of 235
Miyazaki, Y., De Filippis, E., Bajaj, M., Wajcberg, E., Glass, L., Triplitt, C., Cersosimo, E., Mandarino, L. J., & Defronzo, R. A. (2005) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/14746514050050010601 · Cited by 18
Gerich, J. E., Odawara, M., & Terauchi, Y. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x210660 · Cited by 23
Shah, A., Kendall, G., Demme, R. A., Taylor, J. G., Bozorgzadeh, A., Orloff, M. S., Jain, A. K., Abt, P. L., & Zand, M. S. (2005) · Transplantation · doi:10.1097/01.tp.0000173769.09518.f1 · Cited by 18
Kang, X., Wang, C., Chen, D., Lv, L., Liu, G., Xiao, J., Yang, Y., He, L., Chen, L., Li, X., et al. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0327 · Cited by 18
The relationship between estimated average glucose and fasting plasma glucose
Kim, H., Lee, S., Suh, S., Kim, J. H., Lee, M. K., & Park, H. (2013) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0045 · Cited by 17
What Is the Proper Use of Hemoglobin A1c Monitoring in the Elderly?
Alam, T., Weintraub, N., & Weinreb, J. E. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.03.012 · Cited by 17
Manuel-y-Keenoy, B., Vertommen, J., Abrams, P. J., Gaal, L. V., Leeuw, I. D., Messeri, D., & Poscia, A. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.516 · Cited by 18
Ehehalt, S., Wiegand, S., Körner, A., Schweizer, R., Liesenkötter, K., Partsch, C., Blumenstock, G., Spielau, U., Denzer, C., Ranke, M. B., et al. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12461 · Cited by 16
The utility of urinary myo-inositol as a marker of glucose intolerance
Ikezaki, H., Furusyo, N., Okada, K., Ihara, T., Hayashi, T., Ogawa, E., Kainuma, M., Murata, M., & Hayashi, J. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.018 · Cited by 16
Shrestha, L., Jha, B. K., Yadav, B., & Sharma, S. (2013) · Sunsari Technical College Journal · doi:10.3126/stcj.v1i1.8654 · Cited by 16
Evans, M., Judy, W. V., Wilson, D., Rumberger, J. A., & Guthrie, N. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s79450 · Cited by 16
Hyperglycaemia and its relation to cardiovascular morbidity and mortality: has it been resolved?
Yosefy, C. (2003) · Acta Diabetologica · doi:10.1007/s00592-003-0124-9 · Cited by 16
Özmen, Ş., Çil, T., Atay, A. E., Tuzcu, A. K., & Bahçeci, M. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01927.x · Cited by 16
Grading System to Assess Clinical Performance of Closed-Loop Glucose Control
Chassin, L. J., Wilinska, M. E., & Hovorka, R. (2005) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2005.7.72 · Cited by 16
Boutati, E. I., & Raptis, S. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.528 · Cited by 17
Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetes
Monami, M., Lamanna, C., Lambertucci, L., Longo, R. R., Cocca, C., Addante, F., Lotti, E., Masotti, G., Marchionni, N., & Mannucci, E. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344161 · Cited by 15
Targeting prandial hyperglycemia: How important is it and how best to do this?
Monnier, L., & Colette, C. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0064-4 · Cited by 15
Sargın, H., Sargın, M., Altuntaş, Y., Şengül, A. M., Orbay, E., Seber, S., Uçak, S., & Yayla, A. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00167-0 · Cited by 15
Comparison of HbA1c and OGTT for the diagnosis of type 2 diabetes in children at risk of diabetes
Kim, M. S., Jo, D. S., & Lee, D.-Y. (2018) · Pediatrics & Neonatology · doi:10.1016/j.pedneo.2018.11.002 · Cited by 14
Owens, D. R., van Schalkwyk, C., Smith, P., Beer, S. F., Goenka, N., Bain, S., Bootle, S., Robertson, D., Robinson, A., & Shaw, J. (2009) · Practical Diabetes · doi:10.1002/pdi.1339 · Cited by 13
Yamamoto‐Honda, R., Kitazato, H., Hashimoto, S., Takahashi, Y., Yoshida, Y., Hasegawa, C., Akanuma, Y., & Noda, M. (2008) · Endocrine Journal · doi:10.1507/endocrj.k08e-071 · Cited by 13
Abrahamian, H., Francesconi, M., Loiskandl, A., Dzien, A., Prager, R., & Weitgasser, R. (2004) · Diabetes Technology & Therapeutics · doi:10.1089/152091504322783387 · Cited by 13
Xing, Y., Xie, X., Xu, J., Liu, J., He, Q., Yang, W., Zhang, N., Li, X., Wang, L., Fu, J., et al. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1649251 · Cited by 13
Home, P. D., Aroda, V. R., Blonde, L., Guyot, P., Shaunik, A., Fazeli, M. S., Goswami, H. H., Kalra, S., & Pourrahmat, M. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14136 · Cited by 13
Considerations on blood glucose management in Type 2 diabetes mellitus
Home, P., Chacra, A. R., Chan, J. C. N., Emslie-Smith, A. M., Sorensen, L., & Crombrugge, P. V. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.312 · Cited by 13
Ouchi, M., Oba, K., Motoyama, M., Tsunoda, M., Yamashita, H., Aoyama, J., Saigusa, T., Ishii, K., Yano, H., Hashimoto, M., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0155 · Cited by 12
Watada, H., Su, Q., Li, P. F., Iwamoto, N., Qian, L., & Yang, W. Y. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2816 · Cited by 12
Kundury, K. K., & Hathur, B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241830 · Cited by 14
Disfunção endotelial no diabetes melito tipo 1
Bertoluci, M. C., Cé, G. V., da Silva, A. M. V., & Puñales, M. K. (2008) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302008000200030 · Cited by 13
Under-utilization of capillary glucose monitoring by type 2 diabetic patients
Brindisi, M., Hahn, J., Chiasson, J., & RABASA-LHORET, R. P. R. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.05.005 · Cited by 12
The Importance of Monitoring Blood Glucose
Gavin, J. R. (2007) · US Endocrinology · doi:10.17925/use.2007.00.2.42 · Cited by 12
Hajime, M., Okada, Y., Mori, H., Otsuka, T., Kawaguchi, M., Miyazaki, M., Kuno, F., Sugai, K., Sonoda, S., Tanaka, K., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12680 · Cited by 12
Brodows, R. G., Qu, Y., Johns, D., Kim, D. S., & Holcombe, J. H. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x297268 · Cited by 12
Rationale for treatment options for mealtime glucose control in patients with type 2 diabetes
Aronoff, S. L. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1285191 · Cited by 11
Moon, J., Kim, J. Y., Yoo, S., & Koh, G. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2020.35.2.290 · Cited by 11
Hansen, C. C., Olsen, K., Pilegaard, H., Bangsbo, J., Gliemann, L., & Hellsten, Y. (2021) · Physiological Reports · doi:10.14814/phy2.14855 · Cited by 11
Sujanamulk, B. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/19463.8036 · Cited by 11
Lim, L., Brnabic, A. J., Chan, S. P., Ibrahim, L., Paramasivam, S. S., Ratnasingam, J., Vethakkan, S. R., & Tan, A. T. B. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12596 · Cited by 11
Pathak, K., Soares, M. J., Zhao, Y., James, A. P., Sherriff, J. L., & Newsholme, P. (2016) · Nutrition · doi:10.1016/j.nut.2016.12.007 · Cited by 11
Lixisenatide – A New Glucagon-like Peptide 1 Receptor Agonist in the Treatment of Type 2 Diabetes
Vidal, J. (2010) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2013.09.02.76 · Cited by 12
Chen, S., Wu, J. F., Yu, X., Xu, J., & Chen, H. (2010) · Electrophoresis · doi:10.1002/elps.201000181 · Cited by 10
Dworacka, M., Winiarska, H., & Jagodziński, P. P. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.12.002 · Cited by 10
Namayanja, J., & Janeja, V. P. (2012) · Journal of Medical Systems · doi:10.1007/s10916-012-9894-3 · Cited by 10
Jovanovic, L. G. (2009) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721709349587 · Cited by 10
Assessing glycaemic control: self-monitoring of blood glucose
Wilson, D. D., McAllister, G., & West, A. (2011) · British Journal of Nursing · doi:10.12968/bjon.2011.20.15.919 · Cited by 10
Zeolite Improves High-Fat Diet-Induced Hyperglycemia, Hyperlipidemia and Obesity in Mice
Kazuhiro, K. U. B. O., & KAWAI, Y. (2021) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.67.283 · Cited by 9
Diabetes in stiff-person syndrome
Heneberg, P. (2023) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2023.07.005 · Cited by 9
Gómez-Pérez, F. J. (2015) · Revista de Investigación Clínica · doi:10.1016/s0034-8376(25)00224-4 · Cited by 9
Serum IRAP, a Novel Direct Biomarker of Prediabetes and Type 2 Diabetes?
Trocmé, C., Gonnet, N., Tommaso, M. D., Samouda, H., Cracowski, J., Cracowski, C., Lambert-Porcheron, S., Laville, M., Nobécourt, E., Gaddhab, C., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.596141 · Cited by 9
Gredal, C., Rosenfalck, A. M., Dejgaard, A., & Hilsted, J. (2007) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365510601124024 · Cited by 9
Bailey, C. J., & Krentz, A. J. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch29 · Cited by 9
Shah, V. N., Aktürk, H. K., Vigers, T., Pyle, L. L., Oliver, N. S., & Klonoff, D. C. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.0365 · Cited by 8
Ogawa, E., Urakami, T., Suzuki, J., Yoshida, A., Takahashi, S., & Mugishima, H. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej11-0276 · Cited by 8
Strongest correlation of HbA1c with 1-month-earlier glucose levels in type 2 diabetes
Nakazaki, M., Fukushige, E., Koriyama, N., Fukudome, M., Hashiguchi, H., Aso, K., Yano, J., Ikeda, Y., Kato, K., & Tei, C. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2003.09.003 · Cited by 8
Type 2 diabetes mellitus: A disease of the governance of the glucose-insulin system
Trombetta, M., Boselli, L., Cretti, A., Cali, A. M. G., Vettore, M., Caruso, B., Dorizzi, R. M., Avogaro, A., Muggeo, M., Bonora, E., et al. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.05.006 · Cited by 8
Self-citationTacey, A., Qaradakhi, T., Smith, C., Pittappillil, C., Hayes, A., Zulli, A., & Levinger, I. (2020) · Nutrients · doi:10.3390/nu12072108 · Cited by 8
Pioglitazone in the management of Type 2 diabetes and beyond
Sourij, H., & Wascher, T. C. (2007) · Therapy · doi:10.2217/14750708.4.5.517 · Cited by 7
Kumar, A. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.179993 · Cited by 7
Sarwat, S., Ilag, L. L., Carey, M. A., Shrom, D., & Heine, R. J. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02955.x · Cited by 6
Jyothsna, P., Suchitra, M. M., Kumari, M. K., Chandrasekhar, C., Rukmangadha, N., Sachan, A., & Kumar, B. S. (2022) · Journal of Laboratory Physicians · doi:10.1055/s-0042-1757589 · Cited by 8
Clinical decision making: managing postprandial hyperglycemia.
Hurel, S. J., & Mohan, V. (2006) · PubMed · Cited by 6
Monnier, L., & Colette, C. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.16.2857 · Cited by 6
Žďarská, D. J., Hill, M., Kvapil, M., Piťhová, P., & Brož, J. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0379-3 · Cited by 6
Strilka, R., Sjulin, T., Huprikar, N., Cameron, L., Woody, P. W., & Armen, S. B. (2020) · International Journal of Critical Illness and Injury Science · doi:10.4103/ijciis.ijciis_112_19 · Cited by 7
Akhundova, L., Rustamo, Z. R., Alibayo, G. R., Mustafayev, N., & Huseyno, I. M. (2022) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2022.218.225 · Cited by 6
Yang, R., Zhang, W., Wang, X., Wang, S., Zhou, Q., Li, H., Mu, H., Yu, X., Ji, F., Dong, J., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.978520 · Cited by 5
Karl, D. M., Zhou, R., Vlajnic, A., & Riddle, M. C. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03640.x · Cited by 5
Incorporating postprandial and fasting plasma glucose into clinical management strategies
Bode, B. W. (2008) · Insulin · doi:10.1016/s1557-0843(08)80006-1 · Cited by 5
Sartori, M. S., Aragon, F. F., Padovani, C. R., & Pimenta, W. P. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000100008 · Cited by 5
PARKINSON, J. R., Hamrén, B., Kjellsson, M. C., & Skrtic, S. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13069 · Cited by 5
Le, Y., Yang, K., Yang, J., Fu, W., Xiao, W., Wei, R., & Hong, T. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01310-3 · Cited by 4
Glycemic Variability and Type 2 Diabetes Mellitus
Gribovschi, M., ŢIGAN, Ş. “. H. U. O. M. A. P., & HÂNCU, N. “. M. C. (2013) · Applied Medical Informatics (University of Medicine and Pharmacy Cluj-Napoca) · Cited by 4
Wang, Y., Yu, L., Wang, Y., Zhou, J., Wu, Y., Liu, T., Wang, N., & Fu, C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.815357 · Cited by 4
Improving Diabetes Care: A Fijian Diabetes Service Improvement Study
Ibrahim, A. M., & Lawrence, S. S. (2022) · International Journal of Chronic Diseases · doi:10.1155/2022/9486679 · Cited by 4
Kazuhiro, K. U. B. O., KOIDO, A., KITANO, M., Yamamoto, H., & Saito, M. (2016) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.62.416 · Cited by 4
Fukudome, M., Nakazaki, M., Fukushige, E., Koriyama, N., Ikeda, Y., Kato, K., Kimura, T., & Tei, C. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1544 · Cited by 4
Prandial hyperglycemia: Is it important to track and treat?
Hanefeld, M., & Frank, S. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0090-4 · Cited by 4
Average Daily Risk Range-Index of Glycemic Variability-Related Factor in Type 2 Diabetic Inpatients
Park, S. A., Ko, S., Lee, S., Cho, J.-H., Moon, S. D., Jang, S.-A., Song, K., Son, H.-S., Yoon, K., Cha, B. Y., et al. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.1.31 · Cited by 3
Postprandial plasma glucose effects of once-weekly albiglutide for the treatment of type 2 diabetes
Matthews, J. E., Reinhardt, R. R., & Carr, M. C. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1174565 · Cited by 3
Definition and Clinical Significance of Continuous Glucose Monitoring Parameters
Mo, Y., & Jia, W. (2018) · Springer eBooks · doi:10.1007/978-981-10-7074-7_6 · Cited by 3
Yu, J., Zhang, C., Zhang, S., Xiao, W., Pan, X., Liu, Z., Chu, X., Gao, Q., Xu, A., Xu, Z., et al. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12251 · Cited by 3
Sergeevich, A. A., Gusenbekova, D. G., Garrievna, B. S., & Pavlovna, P. A. Y. O. (2020) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20200501.11 · Cited by 3
Contribution of fasting and postprandial plasma glucose to HbA1c
Ollerton, R. L., Luzio, S. D., & Owens, D. R. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01559.x · Cited by 3
Figueiredo, M. D. S. O., Alfenas, R. D. C. G., Franceschini, S. D. C. C., Pelúzio, M. D. C. G., de Azeredo, R. M. C., & Ribeiro, S. M. R. (2006) · Revista de Nutrição · doi:10.1590/s1415-52732006000200006 · Cited by 3
Aging per se does not influence postprandial glucose levels in type 2 diabetes
Magata, Y., Oba, K., Inuzuka, Y., & Nakano, H. (2005) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2005.00282.x · Cited by 3
Relationship between glycohemoglobin and glycated albumin in chronic dialysis patients
Okada, T., Matsumoto, H., Han, M., Shino, T., Nagaoka, Y., Takeguchi, H., Tomaru, R., Iwasawa, H., Wada, T., Gondo, A., et al. (2005) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.38.31 · Cited by 3
Urine Albumin Excretion as a Marker of Acute Glycemic Changes in Isolated Postprandial Hyperglycemia
Shilpasree, A. S., Patil, V. S., Patil, V. P., & Ingleshwar, D. G. (2016) · Journal of Laboratory Physicians · doi:10.4103/0974-2727.187925 · Cited by 3
Safety and efficacy modelling in anti-diabetic drug development.
Hamrén, B. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 3
Schweizer, A., Ball, M., Owens, D. R., Cressier, F., Holmes, D., & Brunel, P. (2002) · The British Journal of Diabetes · doi:10.1177/14746514020020031601 · Cited by 3
Pochuiеva, T. V., Filatova, I. V., Filatova, A. A., & Мірошніченко, О. (2021) · OTORHINOLARYNGOLOGY · doi:10.37219/2528-8253-2021-6-14 · Cited by 2
Kovatchev, B. P., & Cox, D. J. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)84007-2 · Cited by 2
Okada, T., Yamanaka, T., Tomaru, R., Tamekuni, T., Esaki, S., Nango, T., Miyaoka, Y., Nakao, T., & Ikeda, K. (2010) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.43.433 · Cited by 2
Basal or bolus dose, which is the key factor in CSII?
Yang, N., Xue, B., & Lin, P. (2006) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2006.b0763 · Cited by 2
CORRELATES OF THE DIURNAL PLASMA GLUCOSE VARIABILITY IN NON-INSULIN-TREATED TYPE 2 DIABETIC PATIENTS
Bradescu, O. M., Ionescu-Tirgoviste, C., & Paulescu, N. (2008) · Cited by 2
Dworacka, M., Winiarska, H., & Kuczyński, S. (2019) · International Journal of Diabetes and Metabolism · doi:10.1159/000497589 · Cited by 2
What Is the Proper Use of Hemoglobin A1c Monitoring in the Elderly?
Alam, T., Weintraub, N., & Weinreb, J. E. (2005) · Journal of the American Medical Directors Association · doi:10.1097/00130535-200505000-00005 · Cited by 3
Gabbay, M. A. L., Mori, D., Giuffrida, F. M. A., & Dib, S. A. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000600008 · Cited by 2
Бутаева, С. Г., As, A., Викторович, Б. А., & Dolgov, V. V. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh2017891036-39 · Cited by 2
NHG-Standaard Diabetes mellitus type 2
Rutten, G. E. H. M., Grauw, W. D., Nijpels, G., Goudswaard, A., Uitewaal, P. J. M., der Does, F. V., Heine, R. J., van Ballegooie, E., Verduijn, M., & Bouma, M. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_69 · Cited by 2
Metadata
- Authors
- Bonora, E., Calcaterra, F., Lombardi, S., Bonfante, N., Formentini, G., Bonadonna, R. C., & Muggeo, M.
- Affiliations
- University of Verona (IT)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2001-12-01
- Volume
- 24
- Issue
- 12
- Pages
- 2023-2029
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2077702349
- Cited by
- 235
- References
- 28
- Citations by year
- 2024: 1 · 2023: 2 · 2022: 7 · 2021: 5 · 2020: 8 · 2019: 4 · 2018: 6 · 2017: 10 · 2016: 20 · 2015: 10 · 2014: 4 · 2013: 12 · 2012: 7
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, HbA1c, preprandial glucose, postprandial blood glucose, non-insulin-treated diabetes, glycemic control
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Type 2, Fasting, Female, Food, Glycated Hemoglobin, Humans, Male, Middle Aged, Regression Analysis, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review